In 2023, the American Society of Anesthesiology issued a guidance statement about the use of these medications, also known as GLP-1s (glucagon-like peptide-1)
Injury sites show measurable improvement: reduced pain, increased range of motion, or visible tissue filling
Warnings: products sold as PDA or BPC-157 through online vendors are not manufactured under FDA oversight
Every production batch is independently verified through HPLC and LC-MS testing to support consistency, identity, purity, and reliable laboratory research
Documented Preparation Sequence The most-referenced community preparation sequence for the 12.5/2.5 mg vial: hands washed, flat surface prepared with the unopened vial, BAC water, syringes, and alcohol swabs within reach
Lancet 395 , 497506 (2020)